Page last updated: 2024-10-30

metformin and Diabetes Mellitus Type 1.5

metformin has been researched along with Diabetes Mellitus Type 1.5 in 1 studies

Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.

Research Excerpts

ExcerptRelevanceReference
" The diagnosis leaned toward latent autoimmune diabetes in adults, and the therapeutic approach involved cessation of preprandial insulin therapy, regulation, and subsequent discontinuation of basal insulin and introduction of metformin."4.12Diabetic ketoacidosis as first presentation of latent autoimmune diabetes in adults in a patient with hashitoxicosis as first presentation of Hashimoto's thyroiditis: a case report. ( Fousteris, E; Lygnos, D; Xenou, M; Zoupas, I, 2022)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Xenou, M1
Zoupas, I1
Lygnos, D1
Fousteris, E1

Other Studies

1 other study available for metformin and Diabetes Mellitus Type 1.5

ArticleYear
Diabetic ketoacidosis as first presentation of latent autoimmune diabetes in adults in a patient with hashitoxicosis as first presentation of Hashimoto's thyroiditis: a case report.
    Journal of medical case reports, 2022, Aug-03, Volume: 16, Issue:1

    Topics: Adult; Autoantibodies; Diabetes Mellitus, Type 1; Diabetic Ketoacidosis; Hashimoto Disease; Humans;

2022